HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells

Virology

Volumn 326, Issue 2, 2004, Pages 220-230

  De Graaff, Patricia M A ^a   Heidema, Jojanneke ^a   Poelen, Martien C ^b   Van Dijk, Mariska E A ^a   Lukens, Michael V ^a   Van Gestel, Sjef P J ^a   Reinders, Judith ^c   Rozemuller, Erik ^c   Tilanus, Marcel ^c   Hoogerhout, Peter ^b   Van Els, Cecile A C M ^b   Van Der Most, Robbert G ^d   Kimpen, Jan L L ^a   Van Bleek, Grada M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

CD4 T cell; G protein; MHC class II; Peptide; Respiratory syncytial virus

Indexed keywords

AMINO ACID DERIVATIVE; CD4 ANTIGEN; EPITOPE; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG LAVAGE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DP ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INFANT; LEUKOCYTES, MONONUCLEAR; PEPTIDES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 4043115617     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.008     Document Type: Article

References (57)

1. Ahlers J.D., Belyakov I.M., Thomas E.K., Berzofsky J.A. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. J. Clin. Invest. 108:2001;1677-1685
2. al Daccak R., Wang F.Q., Theophille D., Lethielleux P., Colombani J., Loiseau P. Gene polymorphism of HLA-DPB1 and DPA1 loci in Caucasoid population: frequencies and DPB1-DPA1 associations. Hum. Immunol. 31:1991;277-285
3. Alwan W.H., Openshaw P.J. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine. 11:1993;431-437
4. Arnold P.Y., La Gruta N.L., Miller T., Vignali K.M., Adams P.S., Woodland D.L., Vignali D.A. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169:2002;739-749
5. Begovich A.B., Bugawan T.L., Nepom B.S., Klitz W., Nepom G.T., Erlich H.A. A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9489-9493
6. Bembridge G.P., Garcia-Beato R., Lopez J.A., Melero J.A., Taylor G. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J. Immunol. 161:1998;2473-2480
7. Bendelja K., Gagro A., Bace A., Lokar-Kolbas R., Krsulovic-Hresic V., Drazenovic V., Mlinaric-Galinovic G., Rabatic S. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin. Exp. Immunol. 121:2000;332-338
8. Bont L., Heijnen C.J., Kavelaars A., van Aalderen W.M., Brus F., Draaisma J.T., Geelen S.M., van Vught H.J., Kimpen J.L. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur. Respir. J. 14:1999;144-149
9. Brandenburg A.H., Kleinjan A., van Het L.B., Moll H.A., Timmerman H.H., De Swart R.L., Neijens H.J., Fokkens W., Osterhaus A.D. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J. Med. Virol. 62:2000;267-277
10. Carson R.T., Vignali K.M., Woodland D.L., Vignali D.A. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity. 7:1997;387-399
11. Castelli F.A., Buhot C., Sanson A., Zarour H., Pouvelle-Moratille S., Nonn C., Gahery-Segard H., Guillet J.G., Menez A., Georges B., Maillere B. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J. Immunol. 169:2002;6928-6934
12. Celis E., Karr R.W. Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule. J. Virol. 63:1989;747-752
13. Celis E., Larson J., Otvos L. Jr., Wunner W.H. Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4). J. Immunol. 145:1990;305-310
14. Chang J., Braciale T.J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 8:2002;54-60
15. Chang W.L., Audet R.G., Aizenstein B.D., Hogan L.H., DeMars R.I., Klein B.S. T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis. Infect. Immun. 68:2000;502-510
16. Coiras M.T., Alvarez-Barrientos A.M., Diaz G., Arroyo J., Sanchez-Perez M. Evidence for discoordinate regulation of the HLA-DPB1 gene. Tissue Antigens. 60:2002;505-514
17. Constant S.L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322
18. Cunningham A.C., Milne D.S., Wilkes J., Dark J.H., Tetley T.D., Kirby J.A. Constitutive expression of MHC and adhesion molecules by alveolar epithelial cells (type II pneumocytes) isolated from human lung and comparison with immunocytochemical findings. J. Cell Sci. 107(Pt 2):1994;443-449
19. De Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10:2003;133-139
20. De Lerma B.A., Sartoris S., Tosi G., Nicolis M., Accolla R.S. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules. J. Immunol. 153:1994;4530-4538
21. De Waal L., Yuksel S., Brandenburg A.H., Langedijk J.P.M., Sintnicolaas K., Verjans G.M.G.M., Osterhaus A.D.M.E., de Swart R.L. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the Respiratory Syncytial virus G protein. J. Virol. 78:2004;1775-1781
22. Douhan J., Lieberson R., Knoll J.H., Zhou H., Glimcher L.H. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. Med. 185:1997;1885-1895
23. Eckels D.D., Lake P., Lamb J.R., Johnson A.H., Shaw S., Woody J.N., Hartzman R.J. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones. Nature. 301:1983;716-718
24. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.G. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics. 39:1994;230-242
25. Galeazzi M., Sebastiani G.D., Passiu G., Angelini G., Delfino L., Asherson R.A., Khamashta M.A., Hughes G.R. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J. Rheumatol. 19:1992;42-46
26. Garofalo R., Kimpen J.L., Welliver R.C., Ogra P.L. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:1992;28-32
27. Gaston J.S., Life P.F., Jenner P.J., Colston M.J., Bacon P.A. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J. Exp. Med. 171:1990;831-841
28. Glezen P., Denny F.W. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288:1973;498-505
29. Godkin A.J., Davenport M.P., Willis A., Jewell D.P., Hill A.V. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. J. Immunol. 161:1998;850-858
30. Hancock G.E., Tebbey P.W., Scheuer C.A., Pryharski K.S., Heers K.M., LaPierre N.A. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes. J. Med. Virol. 70:2003;301-308
31. Higgins J.A., Thorpe C.J., Hayball J.D., O'Hehir R.E., Lamb J.R. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J. Allergy Clin. Immunol. 93:1994;891-899
32. Jackson M., Scott R. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins. J. Med. Virol. 49:1996;161-169
33. Johnson T.R., Johnson J.E., Roberts S.R., Wertz G.W., Parker R.A., Graham B.S. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72:1998;2871-2880
34. Joshi P., Shaw A., Kakakios A., Isaacs D. Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections. Clin. Exp. Immunol. 131:2003;143-147
35. Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. Type 1 and Type 2 cytokine imbalance inacute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 168:2003;633-639
36. Muczynski K.A., Anderson S.K., Pious D. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. J. Immunol. 160:1998;3207-3216
37. Peretti M., Villard J., Barras E., Zufferey M., Reith W. Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol. Cell. Biol. 21:2001;5699-5709
38. Plotnicky-Gilquin H., Huss T., Aubry J.P., Haeuw J.F., Beck A., Bonnefoy J.Y., Nguyen T.N., Power U.F. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment. Virology. 258:1999;128-140
39. Polack F.P., Teng M.N., Collins P.L., Prince G.A., Exner M., Regele H., Lirman D.D., Rabold R., Hoffman S.J., Karp C.L., Kleeberger S.R., Wills-Karp M., Karron R.A. A role for immune complexes in enhanced respiratory syncytial virus disease. J. Exp. Med. 196:2002;859-865
40. Redondo M., Ruiz-Cabello F., Concha A., Hortas M.L., Serrano A., Morell M., Garrido F. Differential expression of MHC class II genes in lung tumour cell lines. Eur. J. Immunogenet. 25:1998;385-391
41. Robbins P.A., Maino V.C., Warner N.L., Brodsky F.M. Activated T cells and monocytes have characteristic patterns of class II antigen expression. J. Immunol. 141:1988;1281-1287
42. Roman M., Calhoun W.J., Hinton K.L., Avendano L.F., Simon V., Escobar A.M., Gaggero A., Diaz P.V. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 156:1997;190-195
43. Roucard C., Garban F., Mooney N.A., Charron D.J., Ericson M.L. Conformation of human leukocyte antigen class II molecules. Evidence for superdimers and empty molecules on human antigen presenting cells. J. Biol. Chem. 271:1996;13993-14000
44. Rozemuller E.H., Bouwens A.G., Bast B.E., Tilanus M.G. Assignment of HLA-DPB alleles by computerized matching based upon sequence data. Hum. Immunol. 37:1993;207-212
45. Schindler M.B., Cox P.N. A simple method of bronchoalveolar lavage. Anaesth. Intensive Care. 22:1994;66-68
46. Schultz E.S., Lethe B., Cambiaso C.L., Van Snick J., Chaux P., Corthals J., Heirman C., Thielemans K., Boon T., van der B.P. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Cancer Res. 60:2000;6272-6275
47. Shay D.K., Holman R.C., Roosevelt G.E., Clarke M.J., Anderson L.J. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183:2001;16-22
48. Simoes E.A. Respiratory syncytial virus infection. Lancet. 354:1999;847-852
49. Tebbey P.W., Hagen M., Hancock G.E. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 188:1998;1967-1972
50. van Bleek G.M., Poelen M.C., van der Most R.G., Brugghe H.F., Timmermans H.A., Boog C.J., Hoogerhout P., Otten H.G., van Els C.A. Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J. Virol. 77:2003;980-988
51. Varga S.M., Wissinger E.L., Braciale T.J. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J. Immunol. 165:2000;6487-6495
52. Varga S.M., Wang X., Welsh R.M., Braciale T.J. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity. 15:2001;637-646
53. Versluis L.F., Rozemuller E., Tonks S., Marsh S.G., Bouwens A.G., Bodmer J.G., Tilanus M.G. High-resolution HLA-DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum. Immunol. 38:1993;277-283
54. Versluis L.F., Rozemuller E.H., Duran K., Tilanus M.G. Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue Antigens. 46:1995;345-349
55. Watson A.J., DeMars R., Towbridge I.S., Bach F.H. Detection of a novel human class II HLA antigen. Nature. 304:1983;358-361
56. Zeng G., Wang X., Robbins P.F., Rosenberg S.A., Wang R.F. CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3964-3969
57. Zhou H., Su H.S., Zhang X., Douhan J. III, Glimcher L.H. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:1997;4741-4749